Skip to content
Search

Latest Stories

DHSC includes 16 drugs in third August price concessions list

The Department of Health and Social Care (DHSC) has on Thursday (August 27) has included 16 drugs in its third price concession list for August 2020.

DrugPack sizePrice Concession
Alendronic acid 10mg tablets28£5.75
Clonidine 25microgram tablets112£16.11
Entacapone 200mg tablets30£10.33
Erythromycin 250mg gastro-resistant tablets28£4.11
Esomeprazole 40mg gastro-resistant capsules28£4.59
Hydroxyzine 10mg tablets84£1.75
Moxonidine 300microgram tablets28£8.74
Nizatidine 150mg capsules30£7.47
Olanzapine 10mg tablets28£4.23
Prednisolone 20mg tablets30£7.19
Rasagiline 1mg tablets28£20.41
Tacrolimus 0.1% ointment30£24.95
Tacrolimus 0.1% ointment60£46.64
Valproic acid 150mg gastro-resistant capsules100£11.37
Valproic acid 300mg gastro-resistant capsules100£22.77
Valproic acid 500mg gastro-resistant capsules100£30.00

Second price concessions list released on August 21.  


DrugPack sizePrice Concession
Adrenaline (base) 150micrograms/0.15ml (1 in 1,000) solution for injection pre-filled disposable devices1£34.30
Duloxetine 20mg gastro-resistant capsules28£7.74
Duloxetine 40mg gastro-resistant capsules56£12.39
Enalapril 20mg tablets28£7.20
Exemestane 25mg tablets30£41.00
Imipramine 25mg tablets28£6.40
Irbesartan 150mg tablets28£6.80
Moxonidine 200microgram tablets28£9.72
Moxonidine 400microgram tablets28£12.13
Naftidrofuryl 100mg capsules84£6.99
Olanzapine 20mg tablets28£6.77
Prednisolone 10mg tablets30£16.22
Prednisolone 2.5mg tablets30£4.19
Senna 7.5mg tablets60£2.76
Sertraline 50mg tablets28£5.27
Tolterodine 1mg tablets56£16.43

First price concessions list released on August 19.

DrugPack sizePrice Concession
Amiodarone 200mg tablets28£2.41
Donepezil 10mg tablets28£2.13
Enalapril 10mg tablets28£3.95
Estradiol 1mg tablets84£6.89
Estradiol 2mg tablets84£6.89
Sertraline 100mg tablets28£10.49
Tolterodine 2mg tablets56£13.99
Valaciclovir 500mg tablets10£20.59
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets28£11.78

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less